InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GLG | Ann: Removal from Official List | 25/10/12 | 0 | 435 | |||
|
|||||||
GLG | Ann: Scheme Implementation - Resignation of Direc | 23/10/12 | 0 | 329 | |||
|
|||||||
GLG | Ann: Appendix 3Z - Final Director's Interest | 23/10/12 | 0 | 302 | |||
|
|||||||
AMP +GLG | Ann: Ceasing to be a substantial holder from AMP | 15:49 | 0 | 388 | |||
|
|||||||
GLG | Ann: Suspension from Official Quotation | 11/10/12 | 0 | 357 | |||
|
|||||||
GLG | Ann: Lodgement of Court Orders with ASIC | 11/10/12 | 0 | 219 | |||
|
|||||||
GLG | Ann: Federal Court Approves Scheme | 10/10/12 | 0 | 257 | |||
|
|||||||
GLG | Ann: Scheme Meeting Results | 05/10/12 | 0 | 266 | |||
|
See All Discussions